Meeting
2014 Genitourinary Cancers Symposium
Long-term clinical and toxicity outcomes of hypofractionated intensity-modulated radiation therapy for clinically localized prostate cancer.
Authors
Rupesh Kotecha
Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH
Rupesh Kotecha , Michael A. Weller , Gaurav Marwaha , Jason Hearn , Patrick Kupelian , Chandana A. Reddy , Jay P. Ciezki , Kevin L. Stephans , Rahul D. Tendulkar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 49)
DOI
10.1200/jco.2014.32.4_suppl.49
Abstract #
49
Poster Bd #
D5
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter
Poster
2019 Genitourinary Cancers Symposium
Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/fraction).
First Author: Omar Y. Mian
Poster
2022 ASCO Genitourinary Cancers Symposium
Long-term outcomes of a pilot study on highly hypofractionated intensity-modulated radiation therapy over three weeks for localized prostate cancer.
First Author: Kiyonao Nakamura
Poster
2020 Genitourinary Cancers Symposium
Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial.
First Author: David P. Dearnaley